What are Amgen's total assets?

Amgen (AMGN) holds $92.5B in total assets, up 3.5% year over year.

How much debt does Amgen have?

Amgen carries $57.3B in total debt against $9.2B of shareholders' equity, a debt-to-equity ratio of 6.24.

How much cash does Amgen have?

Amgen holds $559.0M in cash and equivalents.

Can Amgen cover its short-term obligations?

Its current ratio is 1.26 — current assets exceed current liabilities.

Where does Amgen's balance sheet data come from?

Every line is extracted from Amgen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Amgen AMGN Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$559M+10.0%	$604M+24.0%	$737M+69.4%	$542M+10.8%	$508M+7.9%
Accounts receivable, net	$9.14B+12.4%	$9.57B+41.1%	$8.49B+16.0%	$8.7B+25.5%	$8.13B+20.0%
Inventories	$6.19B-8.1%	$6.23B-11.0%	$6.35B-13.8%	$6.58B-17.7%	$6.73B-22.9%
Raw materials	$1.05B+24.6%	$915M+11.9%	$955M+21.2%	$885M+0.1%	$841M-9.4%
Work in process	$3.43B-13.5%	$3.43B-16.9%	$3.56B-18.1%	$3.66B-18.3%	$3.96B-24.8%
Finished goods	$1.71B-11.2%	$1.89B-8.5%	$1.84B-17.9%	$2.04B-22.6%	$1.93B-23.7%
Prepaid expenses and other current assets	$4.11B+26.2%	$4.13B+26.1%	$3.6B+17.2%	$3.42B+15.0%	$3.26B+15.5%
Total current assets	$31.48B+16.9%	$29.06B+0.1%	$27.89B+4.2%	$26.73B-1.7%	$26.93B-3.9%
Property and equipment, net	$8.22B+23.0%	$7.91B+20.9%	$7.22B+17.3%	$6.86B+12.4%	$6.68B+11.3%
Accumulated depreciation	$9.3B-12.3%	$11.1B+6.7%	$11B+6.8%	$10.8B+6.9%	$10.6B+7.1%
Goodwill	$18.67B+0.2%	$18.68B+0.2%	$18.68B+0.1%	$18.67B+0.3%	$18.65B+0.4%
Intangible assets, net	$20.67B-16.2%	$21.57B-22.1%	$22.43B-19.4%	$23.9B-17.6%	$24.66B-18.4%
Other non-current assets	$12.76B+12.0%	$12.66B+27.5%	$13.22B+27.3%	$11.02B+25.0%	$11.39B+26.4%
Total investments	$6.01B+9.6%	$6.14B+46.7%	$6.82B+34.8%	$4.9B+41.2%	$5.48B+37.6%
Total assets	$92.5B+3.5%	$90.59B-1.4%	$90.14B-0.8%	$87.9B-3.3%	$89.37B-3.9%
Accounts payable	$2.94B+22.0%	$2.37B+24.1%	$2.84B+32.2%	$3.01B+32.8%	$2.41B+47.8%
Accrued expenses	$16.58B-3.8%	$18.52B+5.0%	$16.8B+14.9%	$15.02B+9.5%	$17.23B+22.0%
Current portion of long-term debt	$5.44B+61.4%	$4.6B+29.5%	$2.15B-39.2%	$2.44B-55.8%	$3.37B-14.9%
Total current liabilities	$24.96B+8.5%	$25.49B+10.3%	$21.79B+7.3%	$20.48B-4.8%	$23.01B+16.7%
Long-term debt	$51.89B-3.9%	$50.01B-11.6%	$52.43B-7.8%	$53.76B-5.9%	$54.01B-10.1%
Other non-current liabilities	$2.37B+7.0%	$2.38B+1.2%	$2.22B+1.1%	$2.34B-1.1%	$2.21B-6.2%
Total liabilities	$965M-1.9%	$988M-12.4%	$999M+0.1%	$1.11B-2.2%	$984M-15.8%
Common stock	2.8B0.0%	2.8B-91.8%	2.8B0.0%	2.8B0.0%	2.8B0.0%
Retained earnings	-$24.65B+9.2%	-$25.11B+9.0%	-$23.8B+6.8%	-$25.71B+5.2%	-$27.14B+2.6%
Accumulated other comprehensive income (loss)	-$190M+17.7%	-$258M-291%	-$422M-25.6%	-$544M-251%	-$231M-21.6%
Total stockholders' equity	$9.19B+48.1%	$8.66B+47.3%	$9.62B+27.8%	$7.43B+25.4%	$6.21B+23.6%
Total liabilities and stockholders' equity	$92.5B+3.5%	$90.59B-1.4%	$90.14B-0.8%	$87.9B-3.3%	$89.37B-3.9%
Available-for-Sale Debt Securities - Amortized Cost	$11.48B+38.3%	$8.53B-25.8%	$8.71B+1.5%	$7.49B-15.0%	$8.3B-10.1%
Cash, Cash Equivalents, and Marketable Securities	$11.48B+38.3%	$8.53B-25.8%	$8.71B+1.5%	$7.49B-15.0%	$8.3B-10.1%
Finished goods	$1.71B-11.2%	$1.89B-8.5%	$1.84B-17.9%	$2.04B-22.6%	$1.93B-23.7%
Other current assets	$4.11B+26.2%	$4.13B+26.1%	$3.6B+17.2%	$3.42B+15.0%	$3.26B+15.5%
Derivative Assets - Fair Value	$249M+27.7%	$244M-41.9%	$142M+26.8%	$109M-59.6%	$195M-13.3%
Deferred Tax Assets and Other Non-Current Assets	$12.76B+12.0%	$12.66B+27.5%	$13.22B+27.3%	$11.02B+25.0%	$11.39B+26.4%
Equity Securities (FV-NI) - Non-Current	$6.01B+9.6%	$6.14B+46.7%	$6.82B+34.8%	$4.9B+41.2%	$5.48B+37.6%
Equity Securities (Non-Current)	$6.01B+9.6%	$6.14B+46.7%	$6.82B+34.8%	$4.9B+41.2%	$5.48B+37.6%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	$2.2B0.0%	——	$2.3B-20.7%	$2.3B-20.7%	$2.2B-24.1%
Finite Lived Intangible Assets - Gross	$54.32B+0.1%	$54.35B-1.3%	$54.3B-1.5%	$54.7B-0.7%	$54.29B-1.4%
Intangible Assets Gross (Excluding Goodwill)	$55.03B-0.6%	$55.06B-1.9%	$55.01B-2.1%	$55.41B-1.4%	$55.35B-1.6%
Investments - Amortized Cost Basis	$11.48B+38.3%	$8.53B-25.8%	$8.71B+1.5%	$7.49B-15.0%	$8.3B-10.1%
Intangible assets — net	$20.67B-16.2%	$21.57B-19.0%	$22.43B-19.4%	$23.9B-17.6%	$24.66B-18.4%
Other intangible assets—net	$21.38B-16.9%	$22.28B-19.6%	$23.14B-20.0%	$24.61B-18.4%	$25.72B-18.0%
Other non-current assets	$12.76B+12.0%	$12.66B+27.5%	$13.22B+27.3%	$11.02B+25.0%	$11.39B+26.4%
Software and Technology Licenses, Net	$12.76B+12.0%	$12.66B+27.5%	$13.22B+27.3%	$11.02B+25.0%	$11.39B+26.4%
Other Commercial Liabilities	$16.58B-3.8%	$18.52B+5.0%	$16.8B+14.9%	$15.02B+9.5%	$17.23B+22.0%
Accrued Liabilities, Current	$16.58B-3.8%	$18.52B+5.0%	$16.8B+14.9%	$15.02B+9.5%	$17.23B+22.0%
Derivative Liabilities - Fair Value	$792M-10.0%	$827M-19.1%	$904M+2.0%	$1.02B-0.8%	$880M-17.9%
Contingent Consideration Liability (Non-Current)	$173M+66.3%	$161M+51.9%	$95M-15.2%	$90M-15.9%	$104M+8.3%
Debt Instrument Face Amount	$4B—	——	——	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$1.33B-1.2%	$1.31B-4.0%	$1.32B-4.1%	$1.33B-4.2%	$1.35B-4.2%
Hedged Liability - Fair Value Hedge	-$183M+25.9%	-$161M+53.1%	-$159M+17.2%	-$186M+46.1%	-$247M+32.0%
Liability For Uncertain Tax Positions Noncurrent	$2.76B+14.3%	$2.69B+14.5%	$2.62B+14.7%	$2.51B+13.9%	$2.42B-39.0%
Other Debt Including Capitalized Leases	$25M-10.7%	$27M+12.5%	$24M-11.1%	$26M-10.3%	$28M-15.2%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common stock	$34.03B+1.3%	$34.02B+1.5%	$33.84B+1.3%	$33.68B+1.4%	$33.58B+1.5%
Share Repurchase Authorization Limit	$6.8B0.0%	——	$6.8B-2.9%	$6.8B-2.9%	$6.8B-2.9%
Share Repurchase Program - Amount Remaining	$6.8B0.0%	——	$6.8B-2.9%	$6.8B-2.9%	$6.8B-2.9%
Unrealized Gains on Investments	$0—	$0—	$0—	$0—	$0—
Unrealized Losses on Investments (Before Tax)	$0—	$0—	$0—	$0—	$0—
Cumulative Cost Basis	$11.48B+38.3%	$8.53B-25.8%	$8.71B+1.5%	$7.49B-15.0%	$8.3B-10.1%
Fair Value Measurement Disclosure	$792M-10.0%	$827M-19.1%	$904M+2.0%	$1.02B-0.8%	$880M-17.9%
Gross Assets/Liabilities	$792M-10.0%	$827M-19.1%	$904M+2.0%	$1.02B-0.8%	$880M-17.9%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$0—	$0—	$0—	$0—	$0—
Gross Unrealized Gains	$0—	$0—	$0—	$0—	$0—
Total	$11.48B+38.3%	$8.53B-25.8%	$8.71B+1.5%	$7.49B-15.0%	$8.3B-10.1%
Available for sale investments	$11.48B+38.3%	$8.53B-25.8%	$8.71B+1.5%	$7.49B-15.0%	$8.3B-10.1%
Business Combination, Contingent Consideration, Liability	$173M+66.3%	$161M+51.9%	$95M-15.2%	$90M-15.9%	$104M+8.3%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$2.75B0.0%	$2.75B0.0%	$2.75B0.0%	$2.75B0.0%	$2.75B0.0%
Common Stock, Shares, Outstanding	$539.7M+0.4%	$538.8M+0.4%	$538.5M+0.2%	$538.3M+0.2%	$537.7M+0.2%
Debt issuances	$4B—	——	——	——	——
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	$1.33B-1.2%	$1.31B-4.0%	$1.32B-4.1%	$1.33B-4.2%	$1.35B-4.2%
Deferred income taxes	$1.34B-11.0%	$1.37B-15.5%	$1.46B-14.8%	$1.39B-22.1%	$1.51B-18.9%
Derivative, gross, assets	$249M+27.7%	$244M-41.9%	$142M+26.8%	$109M-59.6%	$195M-13.3%
Derivatives, gross, liabilities	$792M-10.0%	$827M-19.1%	$904M+2.0%	$1.02B-0.8%	$880M-17.9%
Finite-Lived Intangible Assets, Accumulated Amortization	$33.65B+13.6%	$32.78B+15.3%	$31.87B+16.9%	$30.79B+18.2%	$29.62B+19.2%
2028	$2.8B-24.3%	——	$3.5B-10.3%	$3.7B-5.1%	$3.7B-5.1%
2030	$2.2B0.0%	——	$2.3B-20.7%	$2.3B-20.7%	$2.2B-24.1%
2031	$2.1B0.0%	——	$2.2B0.0%	$2.2B0.0%	$2.1B-4.5%
Remainder of 2026	$2.7B-12.9%	——	$900M-25.0%	$2B-16.7%	$3.1B-13.9%
2027	$3.6B-2.7%	——	$3.6B-20.0%	$3.7B-17.8%	$3.7B-17.8%
2029	$2.3B-17.9%	——	$2.8B-28.2%	$2.9B-25.6%	$2.8B-28.2%
Gross Carrying Amount	$54.32B+0.1%	$54.35B-1.3%	$54.3B-1.5%	$54.7B-0.7%	$54.29B-1.4%
Identifiable Intangible Assets Accumulated Amortization	$33.65B+13.6%	$32.78B+15.3%	$31.87B+16.9%	$30.79B+18.2%	$29.62B+19.2%
Identifiable Intangible Assets Gross	$55.03B-0.6%	$55.06B-1.9%	$55.01B-2.1%	$55.41B-1.4%	$55.35B-1.6%
Amount outstanding under the credit facility	$0—	$0—	——	——	——
Syndicated, unsecured revolving credit facility capacity	$4B—	——	——	——	——
Other (including finance leases)	$25M-10.7%	$27M+12.5%	$24M-11.1%	$26M-10.3%	$28M-15.2%
Share Repurchase Program, Remaining Authorized, Amount	$6.8B0.0%	——	$6.8B-2.9%	$6.8B-2.9%	$6.8B-2.9%
Remainder of Fiscal Year 2024	$2.7B-12.9%	——	$900M-25.0%	$2B-16.7%	$3.1B-13.9%
Remainder of Fiscal Year 2025	$2.7B-12.9%	——	$900M-25.0%	$2B-16.7%	$3.1B-13.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Amgen.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Amgen's total assets?: Amgen (AMGN) holds $92.5B in total assets, up 3.5% year over year.
How much debt does Amgen have?: Amgen carries $57.3B in total debt against $9.2B of shareholders' equity, a debt-to-equity ratio of 6.24.
How much cash does Amgen have?: Amgen holds $559.0M in cash and equivalents.
Can Amgen cover its short-term obligations?: Its current ratio is 1.26 — current assets exceed current liabilities.
Where does Amgen's balance sheet data come from?: Every line is extracted from Amgen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.